Bronwyn Le Grice

Bronwyn Dilley

Bronwyn has 15 years executive experience in the life sciences sector spanning corporate and business development, investor relations and advocacy.

The former CEO of NZBIO, New Zealand’s national life sciences industry body, Bronwyn joined BioScience Managers in 2012, where she was responsible for strategic positioning, marketing and external relations and was a member of the Investment team for two funds totalling AU$96M under management.

Most recently Bronwyn was responsible for managing the NZ$2m pre-IPO and subsequent heavily oversubscribed A$35m IPO of digital health company Adherium Ltd on the ASX. Prior to this she project managed the acquisition of New Zealand company Rex Bionics on behalf of Union Medtech Plc and the merged entity’s subsequent listing on the AIM market, including pre-IPO and IPO capital raisings of £10.98M.

Bronwyn is currently undertaking her Masters of Commercial Law at the University of Melbourne. She has a B.Com from the University of Western Australia and a Professional Certificate (Post Graduate) in Commercialisation from the University of Melbourne. Bronwyn is a Member of the Australian Institute of Company Directors and a Member of Women on Boards.